Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Instagram Outage Disrupts Thousands of U.S. Users 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
MISSION VIEJO, Calif., Sept. 07, 2017 -- MYnd Analytics, Inc. (NASDAQ:MYND), a predictive medicine company which brings objective physical findings to psychiatric treatment in order to reduce trial and error prescribing in mental health, announces that CEO George Carpenter has been invited to present at the Brain Futures 2017 conference. The conference is being held from September 6-7th, 2017 at the Gaylord National Resort in Washington, D.C.
MYnd Analytics CEO George Carpenter will present at 12:50 PM Eastern Time on September 7th, in a session entitled, “From Pharmacogenetics to Psychedelics: Promising Medication Advances.” The session will explore the promise of personalized medicine in reducing trial and error prescribing for the treatment of mental health conditions by combining neuroimaging and genomics.
George Carpenter, CEO of MYnd Analytics, commented, “We are pleased to present at the Brain Futures 2017 Conference, which hosts many of the top mental health professionals from across the country. The session will include a detailed discussion of our ability to increase predictive accuracy of medications through machine learning to assist practitioners in properly treating behavioral health disorders and reducing costs associated with improper treatment. We also plan to discuss new pharmacogenomic variables we are adding to our core data, as well as expansion of our intellectual property portfolio.”
About Brain Futures
Brain Futures is increasing the range of therapeutic options available to the public by bridging the gap between research, innovation and practice and by providing rigorous and unbiased information about advances in brain health and cutting-edge care that is transforming patient outcomes.
About MYnd Analytics
MYnd Analytics, Inc. (www.myndanalytics.com) provides a unique set of reference data and analytic tools for clinicians and researchers in psychiatry. While treatment for mental disorders has doubled in the last 20 years, it is estimated that millions Americans have failed two or more medication therapies for their mental disorders. MYnd Analytics' Psychiatric EEG Evaluation Registry, or PEER Online®, is a registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). Based on MYnd Analytics' original physician-developed database, there are now more than 38,000 outcomes for over 10,000 unique patients in the PEER registry. The goal of PEER Online® is to provide objective, personalized data to assist physicians in the selection of appropriate medications.
To read more about the benefits of this patented technology for patients, physicians and payers, please visit www.myndanalytics.com.
Contact: David Waldman / Natalya Rudman Crescendo Communications, LLC Tel: +1 (212) 671-1020 Email: [email protected]
